000 | 01211 a2200325 4500 | ||
---|---|---|---|
005 | 20250516120840.0 | ||
264 | 0 | _c20131021 | |
008 | 201310s 0 0 eng d | ||
022 | _a1939-2869 | ||
024 | 7 |
_a10.3949/ccjm.79a.12088 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSivalingam, Senthil K | |
245 | 0 | 0 |
_aQ: Should N-acetylcysteine be used routinely to prevent contrast-induced acute kidney injury? _h[electronic resource] |
260 |
_bCleveland Clinic journal of medicine _cNov 2012 |
||
300 |
_a746-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcetylcysteine _xadministration & dosage |
650 | 0 | 4 |
_aAcute Kidney Injury _xchemically induced |
650 | 0 | 4 | _aAdministration, Intravenous |
650 | 0 | 4 |
_aAnaphylaxis _xchemically induced |
650 | 0 | 4 |
_aContrast Media _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aRisk Assessment |
700 | 1 | _aHariharan, Mini V | |
700 | 1 | _aBraden, Gregory L | |
700 | 1 | _aFreda, Benjamin J | |
773 | 0 |
_tCleveland Clinic journal of medicine _gvol. 79 _gno. 11 _gp. 746-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3949/ccjm.79a.12088 _zAvailable from publisher's website |
999 |
_c22238623 _d22238623 |